- Home
- DNUT vs SLDB Comparison
DNUT vs SLDB Comparison
Compare DNUT & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- SLDB
- Stock Information
- Founded
- DNUT 1937
- SLDB 2013
- Country
- DNUT United States
- SLDB United States
- Employees
- DNUT N/A
- SLDB N/A
- Industry
- DNUT Food Chains
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DNUT Consumer Staples
- SLDB Health Care
- Exchange
- DNUT Nasdaq
- SLDB Nasdaq
- Market Cap
- DNUT 505.6M
- SLDB 529.4M
- IPO Year
- DNUT 2021
- SLDB 2018
- Fundamental
- Price
- DNUT $3.48
- SLDB $6.11
- Analyst Decision
- DNUT Buy
- SLDB Strong Buy
- Analyst Count
- DNUT 7
- SLDB 10
- Target Price
- DNUT $7.35
- SLDB $15.00
- AVG Volume (30 Days)
- DNUT 16.6M
- SLDB 1.4M
- Earning Date
- DNUT 08-07-2025
- SLDB 08-12-2025
- Dividend Yield
- DNUT 4.02%
- SLDB N/A
- EPS Growth
- DNUT N/A
- SLDB N/A
- EPS
- DNUT N/A
- SLDB N/A
- Revenue
- DNUT $1,538,841,000.00
- SLDB N/A
- Revenue This Year
- DNUT N/A
- SLDB N/A
- Revenue Next Year
- DNUT $2.30
- SLDB N/A
- P/E Ratio
- DNUT N/A
- SLDB N/A
- Revenue Growth
- DNUT N/A
- SLDB N/A
- 52 Week Low
- DNUT $2.50
- SLDB $2.41
- 52 Week High
- DNUT $12.68
- SLDB $10.37
- Technical
- Relative Strength Index (RSI)
- DNUT 51.00
- SLDB 49.25
- Support Level
- DNUT $3.20
- SLDB $5.87
- Resistance Level
- DNUT $3.47
- SLDB $6.81
- Average True Range (ATR)
- DNUT 0.24
- SLDB 0.46
- MACD
- DNUT -0.04
- SLDB -0.14
- Stochastic Oscillator
- DNUT 50.00
- SLDB 22.22
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.